February 2026

143 Articles

No Section

From algorithms to care: ten principles for responsible deployment of artificial intelligence in healthcare

4 February 2026
Author(s): Federico Cabitza, Walter Ricciardi, Gino Gerosa, Gian Franco Gensini, Serafina Valente

Dear Editor,

Detection of left ventricular hypertrophy through ECG: diagnostic performance and comparison of ten ECG scores in different hypertrophic conditions

30 January 2026
Author(s): Davide Antonio Mei, Kevin Serafini, Jacopo Francesco Imberti, Marco Vitolo, Federica Pollicino, Elisa Battigaglia, Gennaro Procaccia, Michele Cervini, Federico Massari, Andrea Barbieri, Giuseppe Boriani

Different electrocardiographic (ECG) criteria were proposed to improve ECG-based detection of left ventricular hypertrophy (LVH), but external validation data are limited and their diagnostic... more

Multiperspective ultrasonography in COPD exacerbations: Insights into inspiratory muscle recruitment and clinical outcomes

19 January 2026
Author(s): Jun Long, Qiang Shen

We have read with considerable interest the recent investigation by Tabbì and colleagues elucidating inspiratory muscle activity through ultrasonographic assessment in patients with chronic... more

Corrigendum to “The changing landscape of Heart Failure: translating management into the modern era” [European Journal of Internal Medicine (2026) 106633]

11 January 2026
Author(s): Cristina Madaudo, Wasyla Ibrahim, Daniela Noakes, Daniel Bromage, Gianfranco Sinagra, Theresa McDonagh, Antonio Cannata

The authors regret that in Figure 1 the name of the drug Sacubitril/Valsartan was incorrectly reported as sacubutril valsartan. This was a typographical error, and the figure has now been corrected... more

Critical considerations on uric acid in HFmrEF: from biomarker to metabolic integrator. Author's reply

28 December 2025
Author(s): Alexander Schmitt, Michael Behnes, Ibrahim Akin, Tobias Schupp

Dear Editor,

Oral anticoagulant nonprescription at discharge in geriatric patients with atrial fibrillation and reduced expected survival

17 December 2025
Author(s): Enrico Brunetti, Roberto Presta, Chukwuma Okoye, Claudia Filippini, Silvio Raspo, Gerardo Bruno, Marco Marabotto, Fabio Monzani, Angela Sciacqua, Mario Bo

Oral anticoagulant therapy (OAC), with direct oral anticoagulants (DOACs) recommended over vitamin K antagonists (VKAs), is considered the standard of care for patients with atrial fibrillation (AF)... more

Corrigendum to “Natural history of the severe subtype of MYH9-related disease (Epstein syndrome)” [European Journal of Internal Medicine 138 (2025) 6354]

10 December 2025
Author(s): Kazuma Shinno, Shinji Kunishima, Atsushi Sakamoto, Toru Uchiyama, Akira Ishiguro

The authors regret that an error appeared in Fig. 1 of the published article. The panels for Deafness, Renal failure, and Proteinuria inadvertently displayed the Kaplan-Meier curves for the R702C/H... more

Is left ventricular hypertrophy a reliable predictor of renal and cardiac outcome in IgA nephropathy?

8 December 2025
Author(s): Ernesto Paoletti, Elisabetta Bussalino

Cardiovascular disease (CVD) is the most important cause of adverse clinical outcome in chronic kidney disease (CKD), due to shared etiopathogenetic factors and common pathophysiological mechanisms [... more

The changing landscape of heart failure: translating management into the modern era

5 December 2025
Author(s): Cristina Madaudo, Wasyla Ibrahim, Daniela Noakes, Daniel Bromage, Gianfranco Sinagra, Theresa McDonagh, Antonio Cannata

Heart failure (HF) is a complex clinical syndrome associated with high morbidity and mortality, accounting for approximately 2 % of total healthcare expenditures. Despite advances in pharmacological... more

From networks of data to networks of care in clinical medicine: this is not artificial intelligence

24 November 2025
Author(s): Pierfrancesco Novielli, Roberto Bellotti, Mohamad Khalil, Piero Portincasa, Sabina Tangaro

The increasing availability of clinical, omic, and imaging data in clinical medicine opens unprecedented opportunities to uncover hidden patterns and mechanistic insights into disease. Available... more

Survival effect of early high-flow nasal oxygen after extubation: Statistical, methodological, and ethical concerns

11 November 2025
Author(s): Yukio Umeda

We read with great interest the article by Ishihara et al. evaluating the survival impact of early high-flow nasal oxygen (HFNO) following extubation in intensive care patients [1] Although the... more

Clinical Insights

Integrating the lungs and the nervous system: Redefining chronic obstructive pulmonary disease care

20 December 2025
Author(s): Christian Messina

We read with great interest the article by Mannino et al., which offers a thoughtful and balanced discussion on the clinical relevance of comorbidities in chronic obstructive pulmonary disease (COPD... more

Advances in syncope: Recent evidence and clinical implications

5 December 2025
Author(s): Giacomo Ramponi, Marco Paganuzzi, Monica Solbiati, Giorgio Costantino

The purpose of this article is the synthesis of the most relevant advances in syncope research over the last decade, bridging current practice with future directions across settings of care (... more

Commentary

SGLT-2 inhibitors in heart failure with preserved and mildly reduced ejection fraction: a big step forward but still a long way to go

30 January 2026
Author(s): Ricardo Gómez-Huelgas, Luis M. Pérez-Belmonte

Heart failure with preserved ejection fraction (HFpEF) is a complex and multifactorial heart disease that traditionally has had no effective therapy options beyond congestive symptom’s control [1].... more

Hypertriglyceridemia-mediated acute pancreatitis: timely attention for an underdiagnosed and severe disease

27 January 2026
Author(s): Robert C. Verdonk, Wenhua He

In this issue of the European Journal of Internal Medicine a narrative review on hypertriglyceridemia-mediated acute pancreatitis (HTG-AP) is published by Subramanian et al. [1]. This well written... more

To dilate or not to dilate: the puzzle of phenotyping heart failure with mildly reduced ejection fraction

31 December 2025
Author(s): Giorgia Esposito, Alberto M. Marra, Antonio Cittadini

Heart failure (HF) is a significant global health concern burdened by an increasingly prevalent issue in both developed and developing countries [1]. It currently affects over 20 million people... more

Intensification of monitoring for improving detection of atrial fibrillation after a presumed “trigger- induced episode” due to potentially reversible factors: what tools and what implications for decision making?

18 December 2025
Author(s): Giuseppe Boriani, Benedetta Cherubini, Davide Antonio Mei

Atrial fibrillation (AF) is an arrhythmia with an increasing epidemiological burden worldwide[1] even if its precise prevalence cannot be defined, since it is frequently asymptomatic, either in... more

Why we measure frailty: Aligning tools with use

17 December 2025
Author(s): Daniele Giuli, Alessandra Ruspi, Graziano Onder

Frailty has become an increasingly prominent topic of investigation, attracting substantial and growing attention within the scientific community. However, such rapid expansion of interest also... more

A call to action: Bridging glucose monitoring and treatment gaps in inpatient diabetes care

5 December 2025
Author(s): Guillermo Umpierrez, Fernando Gomez-Peralta

Diabetes mellitus remains a major global health challenge, increasing clinical, social, and economic burdens on individuals and healthcare systems. In nearly every region of the world, the rising... more

Editorial

A hierarchized proposal to integrate steatotic liver disease in cardiometabolic care: A new mindset to evaluate MASLD in Internal medicine

23 January 2026
Author(s): D Martínez-Urbistondo, J Carretero Gómez, P Pérez-Martínez

The introduction of direct-acting antivirals against hepatitis C virus (HCV) signaled the end of a major era in liver disease, while simultaneously opening new opportunities for medical research and... more

Internal Medicine Flashcard

Tongue atrophy following unexplained nausea, vomiting, and hiccups

26 January 2026
Author(s): Nobuyuki Ishii, Yuma Sato, Miyuki Miyamoto

A 45-year-old woman was admitted with aspiration pneumonia. She was found to have progressive dysphagia and severe dysarthria. Neurological examination showed a hypernasal voice, diminished gag... more

“Normally distended” bladder in an anuric hemodialysis patient

26 January 2026
Author(s): Koji Muro, Noriko Takahara, Haruyoshi Yoshida

A 72-year-old man with end-stage kidney disease had been on maintenance hemodialysis for 18 years and was completely anuric. He presented with a two-week history of persistent low-grade fever (37 °C... more

Recurrent postprandial mandibular swelling with systemic symptoms: a diagnostic challenge

5 January 2026
Author(s): Satoshi Inaba, Ayano Maruyama, Atsushi Kawashima

A 56-year-old woman with allergic rhinitis presented to the emergency department with severe lower abdominal pain and generalized wheals shortly after lunch. Blood tests and abdominal CT were... more

De Winter‐like electrocardiogram changes in the inferior leads

5 January 2026
Author(s): Wenyi Tang, Liyun Luo, Jian Chen

A 48-year-old man with an unremarkable medical history presented with two hours of persistent chest tightness and heartburn. His electrocardiogram (ECG) on arrival showed 1‑ to 3‑mm upsloping ST‑... more

Double halo sign, abdominal pain and purpura

2 January 2026
Author(s): Romain Batton, Arnaud François, Nicolas Girszyn

A 66-year-old man was admitted to the internal medicine department with subacute abdominal pain and diarrhoea, resulting in a weight loss of 10 kg over three weeks. Shortly thereafter, he developed... more

Demyelinating or compressive myelopathy

2 January 2026
Author(s): Christian Messina

A 29-year-old male presented with an eight-month history of progressive ambulation difficulty and a four-month history of urinary hesitancy. He reported no family history of neurological or... more

Perisplenic fibrosis

15 December 2025
Author(s): Tom Abrassart, Olivier Lucidarme, Julien Haroche

Case 1: A 35-year-old woman presented with diabetes insipidus diagnosed at the age of six years. Ten years after diagnosis, she presented with facial sinus infiltration, pleural thickening, long bone... more

A 74-year-old man with skin thickening and ulcers

22 November 2025
Author(s): Ivânia Soares, Inês Pereira Amaral, Paulo Filipe

A 74-year-old man with hypertension, type 2 diabetes (HbA1c 12 %), and chronic kidney disease (KDIGO IIb) presented to the dermatology emergency department with an eight-month history of progressive... more

Letter to the Editor

Timing and absolute benefit in updated colchicine meta-analysis for coronary artery disease. Author's reply

4 February 2026
Author(s): Patrizia Boracchi, Giuseppe Marano, Ester Luconi, Claudio Cimminiello

Dear Editor

Is there a clinical benefit of mechanical CPR in obesity?

2 February 2026
Author(s): Henning Johann Steffen, Ibrahim Akin, Tobias Schupp

We read with interest the article by Sujanyal et al. investigating the outcomes of LUCAS®-assisted versus manual cardiopulmonary resuscitation (CPR) in obese patients with in-hospital cardiac arrest... more

Unmeasured confounders in residual OSA: The roles of polypharmacy, loop gain, and weight trajectory

31 January 2026
Author(s): Linru Zhong, Xinhai Zhu

We read with interest the article by Vitacca et al. [1] In this retrospective cohort spanning ten years of cardiorespiratory monitoring (CRM), the authors assessed residual respiratory events (rAHI≥... more

Management of ANOCA and suspected microvascular angina: integration of plaque-directed and functional strategies

26 January 2026
Author(s): Lukasz Szarpak, Zbigniew Siudak, Andrea Denegri

We read with interest the Ideas and Opinions article by De Servi and colleagues, who question the current emphasis on invasive coronary function testing (CFT) in patients with angina with no... more

Fractional exhaled nitric oxide in acute exacerbations of chronic obstructive pulmonary disease: Beyond pooled means to individual precision

24 January 2026
Author(s): Liangjun Mou, Liangchun Pan

We read with great interest the meta-analysis by Ambrosino and colleagues evaluating fractional exhaled nitric oxide (FeNO) in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) [1... more

Reconsidering residual sleepiness and respiratory events in treated obstructive sleep apnea

23 January 2026
Author(s): Fan Yuan, Letian Qiao, Yuan Liu

We read with great interest the article by Vitacca and colleagues regarding the persistence of respiratory events and daytime sleepiness in patients treated for obstructive sleep apnea [1]. The study... more

Cerebral small vessel disease: a potential risk modifier for future guidelines on management of dyslipidaemias

22 January 2026
Author(s): Luca Bonanni

Cerebral small vessel disease (cSVD) is a highly prevalent and prognostically relevant condition in older adults, yet it is not specifically addressed in current dyslipidaemia management guidelines.... more

TAPSE/PASP ratio in older HFpEF patients: Prognostic insights and geriatric challenges

21 January 2026
Author(s): Gianluca Pagnoni, Aurora Vicenzi, Francesca Coppi

We read with interest the article by De Matteis et al. on the prognostic role of the TAPSE/PASP ratio in older patients with HFpEF hospitalized for acute heart failure [1]. The authors show that RV-... more

Epicardial adipose tissue assessment for earlier cardiovascular risk prediction: from association to clinical utility

18 January 2026
Author(s): Karol Momot, Michal Pruc, Bartosz Maj, Lukasz Szarpak

Calcaterra and colleagues provide a timely narrative review on epicardial adipose tissue (EAT) as an imaging marker of cardiometabolic risk and a potentially modifiable therapeutic target [1]. Yet... more

Use of continuous morphine infusions in end-of-life care in an internal medicine ward

16 January 2026
Author(s): Matilde Ribeiro-Coimbra, Maria Carolina-Carvalho, Frederico Luís-Batista, Paulo Reis-Pina

The use of continuous opioid infusions at the end of life remains a clinically and ethically sensitive area in acute hospital practice[1,2]. International recommendations emphasize that opioids are... more

Optimizing cardiorenal protection in HFrEF: From pharmacological mechanisms to clinical implementation

11 January 2026
Author(s): Miao Yuan

We read with great interest the review article by Russo et al. titled [1]. The authors provided a comprehensive and timely overview of the "four pillars" of heart failure therapy—RAAS inhibitors,... more

Monitoring for atrial fibrillation recurrence following transient new-onset atrial fibrillation

10 January 2026
Author(s): Linda S Johnson, William F. McIntyre

We thank Yang and colleagues for their interest in our study on the time-to-detection of recurrent atrial fibrillation (AF) in patients with transient new-onset AF detected during hospitalization for... more

Comparison of primary prevention strategy guided by SCORE2 versus coronary artery calcium scoring in a non-diabetic population

7 January 2026
Author(s): Anthony MATTA, Dorota FERRIERES, Pauline COUGOUL, Vanessa NADER, Didier Carrié, Vanina BONGARD, Jean FERRIERES

Cardiovascular disease (CVD) remains the leading cause of death and disability worldwide [1]. The role of preventive medicine in reducing the burden of CVD tends to grow because prevention is better... more

Environmental PM10 exposure and MASLD: Challenges in translating gene–environment interactions into routine clinical care

5 January 2026
Author(s): Ming Zhuang, JiaMin Qin, Lu Li

We read with great interest the article by Di Ciaula et al. exploring the association between long-term PM10 exposure and metabolic dysfunction-associated steatotic liver disease (MASLD) in... more

Advancing beyond multimodality: integrating quantitative imaging biomarkers into the clinical workflow of cardiac amyloidosis. Author’s reply

5 January 2026
Author(s): G Sinigiani, L De Michieli, A. Cipriani

We thank Jiang and colleagues for their interesting Letter [1] and for the generous attention dedicated to our review on multimodality imaging in cardiac amyloidosis (CA) [2]. We greatly appreciate... more

Clinical incidents attended by the internal medicine on-call team at a tertiary care hospital

5 January 2026
Author(s): Victoria Lobo-Antuña, Laura Abenza-Barberá, Francesc Puchades-Gimeno, José Chordá-Ribelles, Sara Carrascosa-García

On-call duty is a cornerstone of hospital-based Internal Medicine, yet it remains one of the least quantified and most debated components of medical practice. Originally conceived to address... more

Survival outcomes with LUCAS-AssiSTED VS MANUal CPR in in-hospital cardiac arrest obese patients

3 January 2026
Author(s): Saurabh Sujanyal, Ivan Huespe, Aayushi Pareek, Devang Sanghavi, Nick Kelly

Obesity has emerged as a global health challenge, contributing not only to chronic disease but also to poorer outcomes in acute, high-acuity situations such as cardiac arrest. In the in-hospital... more

Reassessing the safety signal: Dihydropyridine calcium channel blockers in the era of quadruple therapy for heart failure. Author's reply

2 January 2026
Author(s): Mauro Gori, Luca Fazzini, Renata De Maria

We read with interest the letter by Wang et al [1] regarding our recently published paper on prescription patterns and outcomes associated with dihydropyridine calcium channel blockers (DHP-CCBs)... more

Methodological and generalizability considerations in the study of bleeding risk with rivaroxaban vs apixaban in older VTE patients

1 January 2026
Author(s): Fuli Liu, Yuanming Ba

We read with great interest the nationwide register-based cohort study by Roupe et al., recently published in the European Journal of Internal Medicine [1]. The authors should be commended for... more

Timing and absolute benefit in updated colchicine meta-analysis for coronary artery disease

30 December 2025
Author(s): Xiaoli Zhu, Pengjun Wang, Xiaoxia Zhang, Chunmei Wang

We read with interest the updated systematic review and meta-analysis by Boracchi and colleagues evaluating long-term secondary prevention with low-dose colchicine in patients with coronary artery... more

“One size does not fit all”: Personalized approach to define appropriate level of palliative care in newly diagnosed idiopathic pulmonary fibrosis patients

30 December 2025
Author(s): Ilaria Bassi, Anna Maria Cuomo, Dino Gibertoni, Gilda Giancotti, Stefano Nava

Idiopathic pulmonary fibrosis (IPF) is still a disease in which patients' clinical needs and the delivery of palliative care (PC) are mismatched. International societies recommend integrating PC for... more

Antiplatelet therapy in patients with stable coronary artery disease who require long-term oral anticoagulation

29 December 2025
Author(s): Laurent Fauchier, Mickael Guglieri, Arnaud Bisson, Thibault Lenormand, Gregory Y.H. Lip

Coronary artery disease (CAD) and atrial fibrillation (AF) and frequently coexist, with overlapping cardiovascular risk factors [1]. Oral anticoagulants (OACs) are indicated for AF-related stroke... more

Refining cardio-kidney-metabolic phenotyping to strengthen interpretation and clinical translation in atrial fibrillation

28 December 2025
Author(s): Qianqian Yang, Jiaqi Xu, Yu Qiu, Ke Chen, Xiangdong Yang

We read with great interest the article by Mei and colleagues, who investigated cardiovascular-kidney-metabolic (CKM) domains in a large European cohort of patients with atrial fibrillation (AF) and... more

SGLT2 Inhibitors in musculoskeletal and connective tissue diseases: Is there a role?

28 December 2025
Author(s): Margarida Lucas Rocha, Vítor Silvestre-Teixeira

Dear Editor,

Reconsidering the prognostic significance of fluid volume fluctuations in kidney failure

26 December 2025
Author(s): Rumeng Tang, Dongsen Hu, Xing Hang, Pengfei Xie, Lili Zhang

We read with great interest the recent study by Zoccali and colleagues regarding the association between long term fluid volume fluctuations and mortality in patients with kidney failure [1]. The... more

Quality-of-life outcomes after sleeve gastrectomy versus Roux-en-Y gastric bypass: looking beyond mean differences

23 December 2025
Author(s): Adila Abdulla, Chao Li

We read with great interest the article by ’t Hart et al. reporting long-term quality of life (QoL) outcomes after sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in the SleeveBypass... more

Recombinant hf-SCIg in inflammatory myositis: refining patient selection and outcome assessment

23 December 2025
Author(s): Wangqi Tan

We read with great interest the article by Palermo et al. reporting a multicentre real-world experience with recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin (hf-SCIg) for... more

Challenges in inpatient diabetes care: A single-day snapshot or a shot at the heart of the problem?

21 December 2025
Author(s): Theocharis Koufakis, Dimitrios Patoulias, Ieva Ruža, Burcu Sallarel, Alexandra Kautzky-Willer

We read with great interest the thoughtful comments from Wang et al. [1] regarding our article, “Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-Lowering Agents: Challenges of... more

Stratifying AF ablation recurrence risk: Limitations of BMI and optimized assessment strategies

21 December 2025
Author(s): Jia Xu, Xiaochen Wang

We read with great interest the article by Liao et al. titled “Both underweight and obese patients are prone to relapse after ablation of paroxysmal atrial fibrillation” published in the European... more

Bronchoscopy, ventilator dose and outcomes in severe CAP: Reading the sex signal. Author's reply

20 December 2025
Author(s): Nicolas Garin, Despoina Koulenti, Virginie Prendki, Jordi Rello

Dear Editor

The widening gap between point-of-care ultrasonography course participation and supervision resources

15 December 2025
Author(s): Antonio Leidi, Aurélie Zacharias-Fontanet, Olivier Grosgurin, DOMUS study group

Dear Editor,

Heart failure with preserved ejection fraction in the elderly: Clinical, imaging, and biomarker profiles according to global longitudinal strain by cardiac magnetic resonance

15 December 2025
Author(s): Pau Llàcer, Marina García Melero, María Ángeles Fernández, Pedro Torres, Luis Manzano

Dear editor,

Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease. Author's reply

15 December 2025
Author(s): Marco Lanzillotta, Jens Vikse, Elisabetta Goni, Anna-Maria Hoffmann-Vold, Emanuel Della-Torre

We thank Li and Wang for their thoughtful appraisal of our study and for emphasizing the growing need for phenotype-individualized approaches in IgG4-related disease (IgG4-RD) [1,2]. Their comments... more

On the urgency of redefining endpoints and precision stratification in extended monitoring for atrial fibrillation

11 December 2025
Author(s): Hangzhou Luo, Jikai Li, Peng Dong

McIntyre et al. have made a significant contribution to the growing body of evidence supporting extended ambulatory electrocardiogram monitoring in patients with transient new-onset atrial... more

Enhancing the clinical relevance of BMI in atrial fibrillation ablation: A call for integrating body-composition and peri-left-atrial adipose tissue measures

11 December 2025
Author(s): Lu Cui, Xi-zhuang Gao, Yong Cao

Liao et al. report a multicentre analysis showing a U-shaped association between pre-ablation BMI and post-ablation atrial tachyarrhythmia recurrence in paroxysmal AF [1]. The work is timely and... more

Beyond ejection fraction: Small left ventricular volumes define a high-risk phenotype in acute heart failure with preserved ejection fraction

10 December 2025
Author(s): Gema Miñana, Ernesto Valero, Hector Merenciano, Vicent Bodí, Julio Núñez

In patients with heart failure and reduced ejection fraction (HFrEF), larger indexed left ventricular volumes (iLVEDV) have been traditionally considered a surrogate of lower left ventricular... more

Communicating robustness and sex-specific benefit of SGLT2 inhibitors in HFpEF and HFmrEF

9 December 2025
Author(s): Qiang Li, Haixu Hao, Xiaoxuan Yue, Meng An, Yun Yue

Dear Editor,

Challenges in defining difficult-to-treat rheumatoid arthritis in the elderly: Channeling bias, sarcopenia, and the age paradox

9 December 2025
Author(s): Changyong Chen, Ji Fei, Haozhu Chen, Yuhai Yan, Kaiwei Zhang

We read with great interest the recent original article by Jung et al., entitled “Difficult-to-treat rheumatoid arthritis among elderly patients from the KOBIO registry,” published in the European... more

Integrating sTREM2 into non-invasive pathways for early MASH in MASLD

8 December 2025
Author(s): Wenqi Lv, Xiaoyan Yan

We read with great interest the article by Mahmoudian et al., who evaluated soluble triggering receptor expressed on myeloid cells 2 (sTREM2) as a non-invasive biomarker for early metabolic... more

Beyond systemic biomarkers: Future directions in understanding the inflammatory nexus of obstructive sleep apnea and atrial fibrillation

8 December 2025
Author(s): Qianhui Niu

We read with great interest the article by Hunt et al. entitled “Systemic markers of inflammation and immune activation in patients with obstructive sleep apnea and paroxysmal atrial fibrillation,”... more

West Nile virus infection: New guitars in town for the internal medicine community

4 December 2025
Author(s): Raffaella Gallo, Iolanda Cafarella, Fabian Patauner, Lorenzo Bertolino, Emanuele Durante-Mangoni

Dear Editor,

Advancing beyond multimodality: integrating quantitative imaging biomarkers into the clinical workflow of cardiac amyloidosis

4 December 2025
Author(s): Yonghao Jiang, Suying Wu, Yuantong Xu

We read with great interest the comprehensive narrative review by Sinigiani et al. titled "Multimodality imaging for cardiac amyloidosis: clinical applications and future directions" published in the... more

Clinical implications of the U-shaped association between body mass index and atrial tachyarrhythmia recurrence after paroxysmal atrial fibrillation ablation

3 December 2025
Author(s): Danni Huang, Linping Zhu

We read with great interest the article by Liao et al., which reported that both underweight and obese patients are at increased risk of atrial tachyarrhythmia (ATa) recurrence after catheter... more

Addressing gaps in inpatient diabetes management: A call for integrated multidisciplinary approaches

2 December 2025
Author(s): Lu Zhang, Peng Zhang

We commend Porth et al. for their timely and insightful study, "Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents," which elucidates critical deficiencies in... more

Tirzepatide as adjunct to insulin for the treatment of type 1 diabetes

2 December 2025
Author(s): Dimitrios Patoulias, Eleftherios Teperikidis, Djordje S. Popovic, Paschalis Karakasis, Theocharis Koufakis

Based on the latest published data, global prevalence of type 1 diabetes (T1D) was 8.4 million individuals in 2021, with 18 % of them being younger than 20 years, 64 % aged 20–59 years and 19 % aged... more

Optimization and clinical applicability of monitoring strategies: further exploration of the monitoring of transient new-onset atrial fibrillation recurrence

2 December 2025
Author(s): Yanqiu Yang, Jie Gao, Xinkang Wang

We read with great interest the study by McIntyre et al. on the monitoring time and recurrence detection rate of transient new-onset atrial fibrillation (AF) [1]. The study provides valuable... more

Direct oral anticoagulant dose optimization in cancer-associated thrombosis: Current evidence and implications for extended therapy

30 November 2025
Author(s): Ursula Medeiros Araujo de Matos, Moana Divina Da Silva Santiago, Patrick Froelich Meldola, Swarup Kumar, Ritika Vankina

Cancer-associated thrombosis (CAT) remains a leading cause of morbidity and mortality. Important risk factors in this population include chemotherapy, hormonal therapies, indwelling catheters or... more

Inpatient diabetes management in Europe: The limits of a single-day snapshot

29 November 2025
Author(s): Binqi Wang, Ruikai Zhang, Juan Jin, Qiang He

We read with great interest the article by Porth et al. [1], titled "Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care... more

Body weight extremes and recurrence risk after ablation of paroxysmal atrial fibrillation

29 November 2025
Author(s): Jun Yang, Hanning Zhang

We read with great interest the recent article by Liao et al., entitled “Both underweight and obese patients are prone to relapse after ablation of paroxysmal atrial fibrillation” [1]. The authors... more

Antibiotic use in hospitalized older adults according to WHO AWaRe classification: data from the REPOSI register

25 November 2025
Author(s): Chiara Elli, Chiara Crippa, Luca Pasina, REPOSI, Investigators

Antimicrobial resistance is a growing global concern and represents a major threat to public health [1]. In response, many countries have implemented guidelines aimed at promoting the rational use of... more

Physical activity in systemic vasculitis

21 November 2025
Author(s): Jozélio Freire De Carvalho, Ana Tereza Amoedo Martinez, Thiago Teixeira Mendes

Dear Editor,

Bronchoscopy, ventilator dose and outcomes in severe CAP: reading the sex signal

21 November 2025
Author(s): Yulin Liu, Lu Wang

We read with great interest the analysis conducted by Garin et al. regarding sex-related differences in adults intubated for severe community-acquired pneumonia within the EU VAP CAP platform, which... more

Beyond the algorithm: The human interface of medicine

20 November 2025
Author(s): Luca Bonanni, Ada Cutolo

“You should stand at the right side of the patient’s bed.” [1]

Cognitive impairment in familiar hypercholesterolemia: How much is vascular and how much is confounding? Author's reply

18 November 2025
Author(s): Sabrina Scilletta, Antonino Di Pino, Salvatore Piro, Roberto Scicali

We sincerely thank Messina et al. for their thoughtful and valuable comments regarding our study. We fully acknowledge the importance of the points raised and appreciate their contribution to the... more

Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease

15 November 2025
Author(s): Jingyi Li, Jiamin Wang

We were pleased to read the recent article by Goni et al., entitled “Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of... more

Mepolizumab improves health-related quality of life in patients with hypereosinophilic syndrome

14 November 2025
Author(s): Florence Roufosse, Maria C Cid, Arunangshu Biswas, Yekaterina Poloz

Hypereosinophilic syndrome (HES) is a rare, heterogeneous disorder, characterised by high eosinophil levels (≥1500 cells/µL) and eosinophilic inflammation leading to multiorgan dysfunction and damage... more

Considerations on socioeconomic and hormonal factors in sex- and gender-specific risk of metabolic syndrome

11 November 2025
Author(s): Aysun Isiklar

We read with great interest the article by Alipour et al. entitled “Role of sex and gender-related variables in development of metabolic syndrome” published in the European Journal of Internal... more

Heart failure with preserved ejection fraction in older inpatients: Where diagnostic algorithms meet geriatric reality

10 November 2025
Author(s): Roberto Presta, Enrico Brunetti, Francesco Palmas, Mario Bo

Heart failure with preserved ejection fraction (HFpEF) represents a growing and increasingly prevalent phenotype of heart failure (HF) in older adults, yet its recognition in routine clinical... more

Left ventricular remodeling in IgA nephropathy — clinical applicability and lessons from real-world practice

4 November 2025
Author(s): Binqi Wang, Juan Jin, Qiang He

I read with great interest the study by Jin[1], which examines the prognostic implications of distinct left ventricular (LV) geometric patterns in patients with biopsy-proven IgA nephropathy (IgAN).... more

Anifrolumab for refractory dermatomyositis: Experience from a Spanish cohort

4 November 2025
Author(s): Jorge Álvarez Troncoso, Elena Sendagorta Cudos, Esther Fiz Benito, Ismael Calero Paniagua, Ángel Robles Marhuenda

Dermatomyositis (DM) frequently remains active despite glucocorticoids and conventional immunosuppressants. A type I interferon (IFN-I) gene-expression signature across skin, muscle, and blood... more

Cognitive impairment and vascular injury in familial hypercholesterolemia: Looking beyond the association

3 November 2025
Author(s): Wei Cui, Yiguo Chen, Zedong Cheng

We read with great interest the article by Sabrina Scilletta et al. published in the European Journal of Internal Medicine, which explored the relationship between cognitive function and subclinical... more

Methodological considerations for interpreting the association between central systolic blood pressure and brain health

3 November 2025
Author(s): Hui Chen

We read with great interest the recent article by Yu et al. (2025) [1] in the European Journal of Internal Medicine, which investigated the association between central systolic blood pressure (cSBP... more

Utility of following morning body weight in patients with hyponatremia due to chronic SIAD

30 October 2025
Author(s): Guy Decaux, Alain Soupart

In patients with chronic hyponatremia, SNa must be maintained above 134 mEq/l to minimize associated morbidity [1].

Tezepelumab in severe asthma: Strengthening real-world evidence and addressing unresolved clinical questions

28 October 2025
Author(s): Jiamin Wang, Jingyi Li

We were pleased to read the recent article by Poto et al. entitled “Effectiveness of tezepelumab in severe asthma: A multicenter real-world study,” published in the European Journal of Internal... more

Meta-analysis of the relationship between internal microplastic and health outcomes

25 October 2025
Author(s): Xiao Liu, Jiaxue Xu, Zexuan Wang, Haisheng Wu, Peng Yu

Dear editor,

Understanding the threat of West Nile virus infection. Comment on prevention and therapy

10 October 2025
Author(s): Salvatore Chirumbolo, Luigi Valdenassi, Umberto Tirelli, Marianno Franzini

We read with interest the article from Gallo et al., which provides a clear and structured overview of the West Nile virus (WNV), particularly valuable for clinicians unfamiliar with its clinical... more

Original Article

Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis

4 February 2026
Author(s): Valentin Maisons, Antoine Hankard, Alojzija Hočevar, Evangeline Pillebout, Jean-Michel Halimi, Bénédicte Sautenet, Christelle Barbet, Noémie Jourde-Chiche, Alexandre Karras, Jean-François Augusto, Xavier Puéchal, Stanislas Faguer, Christian Lavigne, Kim Baud, Alexis Archambeaud, Hubert de Boysson, Achille Aouba, François Maillot, Benjamin Terrier, Yann Nguyen, Alexandra Audemard-Verger

IgA vasculitis (IgAV) is a systemic vasculitis of the small vessels characterized by immune complexes including immunoglobulin A1 (IgA1) [1]. The clinical picture is a vascular purpura with or... more

Impact of chronic kidney disease on treatment implementation and prognosis of patients with heart failure: A large retrospective observational analysis from the Italian Network-Heart Failure (IN-HF) registry

29 January 2026
Author(s): Matteo Bianco, Samuela Carigi, Renata De Maria, Carola Griffith Brookles, Willy Joelle Mahadie Kamgaing, Luisa De Gennaro, Concetta Di Nora, Paolo Manca, Maria Vittoria Matassini, Vittoria Rizzello, Maria Denitza Tinti, Vittorio Palmieri, Marco Gorini, Francesco Orso, Mauro Gori

In contemporary cohorts of stable heart failure (HF) outpatients, the prevalence of renal dysfunction varies upon definition, but may approach 70% [1]. Hemodynamic and metabolic alterations resulting... more

Incidence of major adverse cardiovascular events decreases with greater adherence to both Mediterranean and low-fat dietary patterns in secondary prevention patients: a randomized controlled trial

27 January 2026
Author(s): Javier Delgado-Lista, Juan F Alcala-Diaz, Jose D Torres-Peña, Gracia M Quintana-Navarro, Antonio P Arenas Larriva, Francisco Fuentes, Antonio Garcia-Rios, Elena M Yubero-Serrano, Oriol A Rangel-Zuñiga, Antonio Camargo, Fernando Rodriguez-Cantalejo, Niki Katsiki, Pablo Perez-Martinez, Jose Lopez-Miranda, CORDIOPREV Investigators

Diet plays a crucial role in lifestyle interventions for secondary cardiovascular prevention [1–5]. Recent guidelines for reducing cardiovascular risk in secondary prevention populations recommend,... more

Mechanistic insights into heart failure progression and therapeutic target discovery through plasma microRNA profiling: Findings from HOMAGE

26 January 2026
Author(s): David de Gonzalo-Calvo, María C. García-Hidalgo, Shambhabi Chatterjee, Sabrina Thum, João Pedro Ferreira, Patrick Rossignol, Nicolas Girerd, Job AJ Verdonschot, Stephane Heymans, Jan A Staessen, John GF Cleland, Faiez Zannad, Thomas Thum, Christian Bär

Identifying early pathobiological mechanisms associated with the onset and progression of heart failure (HF) could guide development of preventive strategies.

Optimizing patient selection for patent foramen ovale closure after stroke: The CRISP-PFO score

12 January 2026
Author(s): Gianluca Rigatelli, Giuseppe Marchese, Ervis Hiso, Andrea Bertolini, Giuseppe Sammarco, Francesca Prevedello, Francesca Caneve, Santina Da Ros, Gabriele Braggion, Marco Zuin

Although patent foramen ovale (PFO) transcatheter closure lowers recurrent cryptogenic stroke (CS), identifying patients who benefit most remains challenging. We developed, validated and assessed the... more

Pre- and in-hospital lactate ratio as a predictor of mortality in severe diabetic ketoacidosis: a multicenter prospective cohort study

10 January 2026
Author(s): Fernando Sebastian-Valles, Miguel Antonio Sampedro-Nuñez, Jose Alfonso Arranz-Martin, Victor Navas-Moreno, Mónica Marazuela, Raúl López-Izquierdo, Carlos del Pozo Vegas, Joseba Rabanales Soto, José Luis Martín-Conty, Ancor Sanz-García, Francisco Martín-Rodríguez

Lactate kinetics between prehospital and in-hospital measurements have been associated with prognosis in acute conditions. This study aimed to evaluate the prognostic value of the prehospital-to-... more

Adrenal insufficiency following systemic glucocorticoid therapy: a systematic review and meta-analysis

10 January 2026
Author(s): Jonathan Bowley, Sophie Shallish, Natasha Smyth, Stephanie Lax, Fiona Pearce

Adrenal insufficiency (AI) is a common complication following glucocorticoid (GC) therapy. However, reliable predictors of AI and GC regimens that mitigate this risk remain unclear. Previous... more

Inflammatory spectrum of frailty: Association between the systemic immune-inflammation index and frailty in liver transplant candidates

9 January 2026
Author(s): Miguel Sogbe, Seong W. Park, Brittany Bromfield, Roberto Tellez, Christopher B. Hughes, Astrid Ruiz-Margáin, Andres Duarte-Rojo

Frailty is common among patients with advanced chronic liver disease (AdvCLD), progressively impairing physical fitness as the disease worsens [1]. It is characterized by reduced physiological and... more

Left atrial appendage closure in patients with hereditary hemorrhagic telangiectasia and atrial fibrillation: a prospective study and systematic review

6 January 2026
Author(s): R Torres-Iglesias, L Teruel, MA Sánchez-Corral, P Cerdà, B Villanueva, E Gamundí, P Peláez, S Moreno-Lopes, A Iriarte, E Alba, A Portillo, J Gómez-Lara, J Ribas, A Riera-Mestre

Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant vascular disease with a high risk of iron deficiency anemia secondary to epistaxis and gastrointestinal bleeding. Atrial... more

Growth differentiation factor-15 in patients presenting with acute chest pain: Diagnostic and prognostic utility

2 January 2026
Author(s): Luca Crisanti, Jonas Glaeser, Pedro Lopez-Ayala, Luca Koechlin, Paolo Bima, Emel Kaplan, Jasper Boeddinghaus, Lena C. Maeder, Katharina Rentsch, Oscar Miro, Michael Christ, Javier F. Martin-Sanchez, Beata Morawiec, Felix Mahfoud, Ivo Strebel, Christian Mueller, APACE investigators

Each year, over 15 million patients present to the emergency department (ED) in North America and Europe with suspected acute myocardial infarction (AMI) [1,2]. Clinical practice guidelines highlight... more

Residual respiratory events and daytime sleepiness despite management of obstructive sleep apnoea with and without additional central apnoeas. A three-month follow-up study

29 December 2025
Author(s): Michele Vitacca, Beatrice Salvi, Carla Simonelli, Eugenio Vitacca, Giuseppina Gaia, Paola Andreoni, Nicolino Ambrosino, Mara Paneroni

Despite treatment, individuals with obstructive sleep apnoea (OSA) may still exhibit high apnoea and hypopnoea indices (AHI) and excessive daytime sleepiness (EDS). We recorded residual respiratory... more

Recent trends and future projections of atrial fibrillation epidemiology in a large european population

27 December 2025
Author(s): Julián Rodríguez-García, Rafel Ramos, Jordi Blanch, Anna Ponjoan, Paolo D. Dallaglio, Rodolfo San Antonio, Marcos Rodríguez-García, Jordi Mercé, Jesús Rodríguez-Silva, Javier Sanaú, Ismael Almonte, Carlos García-Filloy, Josep Comín-Colet, Ignasi Anguera, Andrea Di Marco

Atrial fibrillation (AF) is a major public health concern with a rising global epidemiological burden and marked regional variability. We analysed AF epidemiology, trends, and future projections in a... more

Risk of endocarditis in patients with bacteraemia by coagulase-negative staphylococci; a multicenter retrospective cohort

27 December 2025
Author(s): Virgile Zimmermann, Nicolas Fourré, Bruno Ledergerber, Jana Epprecht, Berit Siedentop, Pierre Monney, Michelle Frank, Benoit Guery, Georgios Tzimas, Laurence Senn, Lars Niclauss, Matthias Kirsch, Mathias Van Hemelrijck, Omer Dzemali, Barbara Hasse, Matthaios Papadimitriou-Olivgeris

Infective endocarditis (IE) is a serious and under-recognized complication of coagulase-negative staphylococci (CoNS) bacteraemia. The aim was to identify predictors of IE in patients with CoNS... more

Association between interleukin-6, C-reactive protein and chronic kidney disease outcomes: A systematic review and meta-analysis

24 December 2025
Author(s): Sama Mahmoud Abdel-Rahman, Lasin Ozbek, Arif E. Narin, Derya G. Fidan, Zeynep Y. Yilmaz, Helin I. Orak, Mustafa Guldan, Mehmet Kanbay

Chronic kidney disease (CKD) is a progressive disorder defined by structural or functional kidney abnormalities persisting for at least three months. According to KDIGO criteria, CKD is diagnosed by... more

Ultrasound-based evaluation of inspiratory muscle effort in patients with type 2 respiratory failure secondary to exacerbation of chronic obstructive pulmonary disease

16 December 2025
Author(s): Luca Tabbì, Alessandro Marchioni, Jacopo Messina, Sara Bombelli, Daniele Puggioni, Riccardo Fantini, Giulia Bruzzi, Stefania Cerri, Bianca Beghè, Enrico Clini, Roberto Tonelli, MUSE-COPD study group

Exacerbations of chronic obstructive pulmonary disease (ECOPD) are a major cause of acute hypercapnic respiratory failure. Diaphragmatic dysfunction is common, often accompanied by compensatory... more

Fractional exhaled nitric oxide in acute exacerbations of chronic obstructive pulmonary disease: A meta-analysis with meta-regressions

28 November 2025
Author(s): Pasquale Ambrosino, Claudio Candia, Stefano Sanduzzi Zamparelli, Giuseppina Marcuccio, Fabio Manzo, Giorgio Alfredo Spedicato, Christian Basile, Costantino Mancusi, Ennio Lubrano, Guido Grassi, Andrea Motta, Mauro Maniscalco

Fractional exhaled nitric oxide (FeNO) has emerged as a useful tool for monitoring airway inflammation in chronic obstructive pulmonary disease (COPD) patients. We designed a systematic review and... more

Robustness of randomized controlled trial evidence for SGLT2 inhibitors in heart failure with preserved and mildly reduced ejection fraction

27 November 2025
Author(s): Marco Zuin, Pierluigi Temporelli, Claudio Bilato, Alberto Corsini, Fabrizio Oliva, Gianluigi Savarese, Raffaele De Caterina

Sodium–glucose co-transporter 2 inhibitors (SGLT2i) have emerged as a fundamental therapy for patients with heart failure with preserved ejection fraction (HFpEF), a population that has historically... more

Effects of calcium channel blockers on GDMT prescription and outcomes according to ejection fraction: IN-HF real world data

12 November 2025
Author(s): Mauro Gori, Luca Fazzini, Jennifer Meessen, Raul Limonta, Samuela Carigi, Matteo Bianco, Luisa De Gennaro, Concetta Di Nora, Paolo Manca, Maria Vittoria Matassini, Vittoria Rizzello, Denitza Tinti, Aldo Pietro Maggioni, Francesco Orso, Marco Gorini, Renata De Maria, Italian Network on Heart Failure (IN-HF) Investigators

Dihydropyridine calcium channel blockers (DHP-CCB) are widely used in heart failure (HF), despite the lack of data regarding their safety, especially in patients with reduced ejection fraction (HFrEF... more

Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care identified by EFIM’s Diabesity Day Survey 2024

8 November 2025
Author(s): Ann-Kristin Porth, Anete Palma, Burcu Sallarel, Dimitrios Patoulias, Dirk Müller-Wieland, Dror Dicker, Ieva Ruža, Ilya Davidenko, Jan Škrha, Julia Brandts, Ricardo Gomez-Huelgas, Shiran Gruber, Sindija Smirnova, Theocharis Koufakis, Yusuf Ziya Sener, Zuzana Kršáková, Alexandra Kautzky-Willer, EFIM Diabetes and Obesity Working Group

People with diabetes and people with obesity have an increased risk of hospitalisation, tend to have longer hospital stays, and have higher mortality when hospitalised (1–3). Diabetes management... more

Both underweight and obese patients are prone to relapse after ablation of paroxysmal atrial fibrillation

25 October 2025
Author(s): Yu Liao, Chintan Trivedi, Michela Casella, Sanghamitra Mohanty, Luigi Di Biase, Selene Cellucci, Momen Ibrahim, Tejas S Khurana, Wilber Su, J. Peter Weiss, Michael Zawaneh, Antonio Dello Russo, Changsheng Ma, Claudio Tondo, Andrea Natale, Rong Bai

Being overweight has been associated with arrhythmia recurrence after atrial fibrillation (AF) ablation, but the optimal threshold to identify high risk patients has not been well established.... more

Left ventricular remodeling in IgA nephropathy: Prognostic implications and clinical correlations

11 October 2025
Author(s): Lu-Hua Jin, Qian Zhou, Gui-Xin Huang, Yi-Qin Wang, Peng-An Li, Li Tan, Wei Chen, Qiong Wen

The determinants and prognosis of left ventricular (LV) geometric remodeling remain uncharacterized in immunoglobulin A nephropathy (IgAN). We investigated the (1) clinicopathological correlates of... more

Monitoring time-to-detection of recurrent atrial fibrillation in patients with transient new-onset atrial fibrillation detected initially during hospitalization for noncardiac surgery or medical illness

9 October 2025
Author(s): William F. McIntyre, Linda S. Johnson, Alexander P. Benz, Maria E. Vadakken, Nicole R. Latendresse, Chinthanie Ramasundarahettige, Faith Kirabo, Jorge A. Wong, Jason D. Roberts, Jeff S. Healey

Approximately one-third-of patients with transient new-onset atrial fibrillation (AF) during hospitalization for noncardiac surgery or medical illness will have recurrent AF within 1 year when... more

Endothelin-1 as dual marker for renal function decline and associated cardiovascular complications in patients with chronic kidney disease

8 October 2025
Author(s): Laura González-Rodríguez, Manuel Martí-Antonio, Sonia Mota-Zamorano, Celia Chicharro, Bárbara Cancho, Enrique Luna, Álvaro Álvarez, Zoraida Verde, Fernando Bandrés, Nicolás R Robles, Guillermo Gervasini

Cardiovascular (CV) complications are the leading cause of death in patients with chronic kidney disease (CKD). Endothelin-1 (ET-1), a potent vasoconstrictor involved in both renal and vascular... more

Prognostic role of TAPSE/PASP ratio among older patients with acute heart failure and preserved ejection fraction

7 October 2025
Author(s): Giuseppe De Matteis, Amato Serra, Maria Livia Burzo, Francesco De Vito, Maria Anna Nicolazzi, Antonio Iaconelli, Antonio Gasbarrini, Francesco Franceschi, Giovanni Gambassi, Marcello Covino

Right ventricular (RV)-pulmonary circulation (PC) uncoupling is associated with poor outcome in patients with Heart Failure with Preserved Ejection Fraction (HFpEF). Tricuspid annular plane systolic... more

Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry

30 September 2025
Author(s): Davide Antonio Mei, Jacopo Francesco Imberti, Marco Vitolo, Giulio Francesco Romiti, Bernadette Corica, Marta Mantovani, Niccolò Bonini, Benedetta Cherubini, Francisco Marin, Igor Diemberger, Gheorghe Andrei Dan, Tatjana Potpara, Marco Proietti, Gregory Y.H. Lip, Giuseppe Boriani

Cardiovascular, kidney, and metabolic (CKM) conditions frequently coexist with atrial fibrillation (AF), but their impact in AF population remains poorly characterized.

Prognostic impact of left ventricular dilatation in heart failure with mildly reduced ejection fraction

16 September 2025
Author(s): Henning Johann Steffen, Michael Behnes, Jonas Dudda, Alexander Schmitt, Noah Abel, Felix Lau, Marielen Reinhardt, Thomas Bertsch, Kathrin Weidner, Daniel Duerschmied, Ibrahim Akin, Tobias Schupp

This study investigated the prognostic value of left ventricular (LV) dilatation in patients with heart failure with mildly reduced ejection fraction (HFmrEF).

Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry

25 August 2025
Author(s): Paolo Prandoni, Meg Fluharty, Sebastian Schellong, Henri Bounameaux, Sylvia Haas, Lorenzo G Mantovani, Sherif Sholkamy, Katsuhiro Kondo, Harry Gibbs, Zhi-Cheng Jing, Chern-En Chiang, Peter Verhamme, Alexander GG Turpie, Jeffrey I. Weitz, Walter Ageno, Shinya Goto, Pantep Angchaisuksiri, Karen Pieper, Ajay K Kakkar, GARFIELD-VTE Investigators

Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is a major cause of morbidity and mortality [1] VTE is linked to several risk factors, including age,... more

An exploratory model for short-term risk stratification in intermediate-high-risk pulmonary embolism running head: The STAMP score

20 August 2025
Author(s): Marco Zuin, Claudio Bilato, Iolanda Enea, Amedeo Bongarzoni, Franco Casazza, Loris Roncon, Cecilia Becattini

Patients with acute pulmonary embolism (PE) characterized by hemodynamic stability, evidence of right ventricular (RV) dysfunction (RVD), positive cardiac biomarkers and high simplified pulmonary... more

Review Article

Precision medicine with pioneering RNAi therapeutics in ATTR amyloidosis: from bench to bedside

1 February 2026
Author(s): Silvia Malinverni, Giuseppe Vergaro, Guglielmo Verona, Aldostefano Porcari

Transthyretin (ATTR) amyloidosis is a multisystem disease caused by misfolding and aggregation of the plasma protein transthyretin (TTR) into insoluble amyloid fibrils in various organs [1]. This... more

Detecting dementia symptoms in internal medicine settings: clinical red flags, frailty and intervention perspectives

7 January 2026
Author(s): Cira Fundarò, Marina Maffoni

This paper provides a comprehensive overview of dementia in internal medicine hospital settings, highlighting its clinical detection, key red flags and frailty factors, as well as intervention... more

Prevention and treatment of hypertriglyceridemia-mediated acute pancreatitis: A narrative review

23 December 2025
Author(s): Savitha Subramanian, Handrean Soran, Asia Sikora Kessler, Monica R. McClain, Robert H. Eckel, Robert S. Rosenson

Acute pancreatitis can result in death or serious consequences including chronic pancreatitis, diabetes mellitus, and organ failure. Causes of acute pancreatitis include gallstones, alcohol, and... more

Renal protection in heart failure with reduced ejection fraction: not all that glitters is gold

16 December 2025
Author(s): Elisa Russo, Emilio Venturelli, Giovanna Leoncini, Francesca Viazzi, Roberto Pontremoli

Chronic kidney disease (CKD) is prevalent among patients with chronic heart failure (CHF), largely due to shared risk factors such as hypertension, diabetes, and dyslipidemia. In patients with heart... more

Medical cannabis and the hype cycle: Clinical evidence and future directions

10 December 2025
Author(s): Ran Abuhasira, Victor Novack

Medical cannabis has moved from a taboo subject to a mainstream clinical discussion over the past three decades. This review synthesizes the evidence and frames its progression using a Hype Cycle... more

The neuro-cardiac axis in epilepsy

4 December 2025
Author(s): Theodora A. Manolis, Antonis A. Manolis, Apostolos Vouliotis, Antonis S. Manolis

Epilepsy is one of the major noncommunicable neurological disorders (the other comprising migraine, Alzheimer disease/other dementias, Parkinson’s disease, motor neuron diseases, multiple sclerosis,... more

The evolving landscape of screening, management and treatment strategies of aortic stenosis in ATTR amyloidosis

28 November 2025
Author(s): Aldostefano Porcari, Matteo Serenelli, Rossana Bussani, Gianfranco Sinagra, Lucia Venneri

Transthyretin amyloid cardiomyopathy (ATTR-CM) and aortic stenosis (AS) frequently coexist in elderly patients, particularly men, creating a complex clinical scenario with overlapping symptoms and... more

Cardiovascular Risk Assessment: Practical Tips for the Internal Medicine Specialist

23 November 2025
Author(s): Fernando A. Rivera, Ridwan Ahmad, Jorge Trejo-Gutierrez

Cardiovascular diseases remain the leading cause of mortality worldwide, and they also represent a significant burden in terms of health care expenditure, equipment use, therapeutic interventions and... more

Frailty measurement in research and clinical practice: An updated review

20 November 2025
Author(s): Elsa Dent, Peter Hanlon, Paul Kowal, Emiel O. Hoogendijk

Frailty is a highly prevalent geriatric condition, affecting between 12–24% of older adults globally. It remains a major cause of morbidity and mortality in older adults. Incorporating frailty... more

Drug-induced rise in serum creatinine: cystatin C to the rescue? Evidence, pitfalls and knowledge gaps

11 November 2025
Author(s): Elliott Van Regemorter, Eléonore Ponlot, Lidvine Boland, Valentine Gillion, Arnaud Devresse

Serum creatinine (SCr) concentration is a cheap biomarker of kidney function measured globally millions of times every day. It is part of the KDIGO definitions of both chronic kidney disease and... more

Multidisciplinary strategies and new technologies in the management of sarcoidosis

31 October 2025
Author(s): Claudio Tana, Marjolein Drent, Ogugua Ndili Obi, Francesco Cinetto, Nicol Bernardinello, Livia Moffa, Marco Tana, Dominique Israël Biet, Paolo Spagnolo

Sarcoidosis exemplifies the complexity of modern internal medicine, requiring comprehensive, system-based management. The disease is characterized by non-caseating granulomas and can affect virtually... more

Multimodality imaging for cardiac amyloidosis: clinical applications and future directions

29 October 2025
Author(s): G Sinigiani, L De Michieli, S Nistri, D Cecchin, D Mele, A Cipriani

Systemic amyloidosis are a group of disorders characterized by the extracellular deposition of misfolded protein fibrils [1]. When the heart is involved, the condition is referred to as cardiac... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.